Electroacupuncture of Scalp Motor Area to Improve Post-Stroke Wrist

Status Completed

Clinical Trial Summary

The goal of this clinical trial is to compare the clinical efficacy of electroacupuncture and manual acupuncture in stimulating the scalp motor area for treating post-stroke wrist dyskinesia and its influence on the function of wrist movement-related active muscles. The main question it aims to answer is: which method of stimulating the scalp motor area is more effective in the recovery of wrist motor function after stroke? Participants will be given routine Western medicine treatment and acupuncture treatment on the hemiplegic side. In the manual acupuncture group, participants will be needled in the scalp motor area on the lesion side. The same acupoint was selected as the manual acupuncture group in the electroacupuncture group. The score of Chinese Stroke Scale (CSS), the score of the upper limb of the Barthel Index (BI), the active range of motion (AROM) of wrist joint, and the surface electromyography (sEMG) was used to measure the root mean square (RMS) of extensor carpi radialis longus, extensor digitorum, flexor carpi radialis and flexor carpi ulnaris on the hemiplegic side of the patients before and after the 3-week treatment period, respectively compare the clinical efficacy of the two groups.

Clinical Trial Description

Participants will be randomly divided into an electroacupuncture group and a manual acupuncture group according to a ratio of 1: 1. In the manual acupuncture group, participants will be needled in the scalp motor area on the lesion side and left in place for 30 minutes after obtaining qi. During needle retention, the needles will be intermittently twisted for 2min twice, with a frequency of about 200 r/min. The same acupoint was selected as the manual acupuncture group in the electroacupuncture group. After obtaining qi, electroacupuncture stimulation will be applied using a continuous wave at a frequency of 2 Hz. The stimulation intensity will be adjusted based on the patient's tolerance, and each treatment will be lasted for 30 minutes. Participants patients in both groups will be treated once a day and rest for one day after six consecutive days of treatment, for a total of three weeks. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT06208059
Study type	Interventional
Source	Heilongjiang University of Chinese Medicine
Contact
Status	Completed
Phase	N/A
Start date	July 1, 2021
Completion date	January 1, 2023

View Details

See also
Status	Clinical Trial	Phase
Active, not recruiting	`NCT05623644` - Multimodal MR Imaging Study on ET and PD Patients Subjected With MRgFUS Thalamotomy
Active, not recruiting	`NCT03548779` - North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2	N/A
Completed	`NCT03295786` - Clinical Study to Test the Safety of CDNF by Brain Infusion in Patients With Parkinson's Disease	Phase 1/Phase 2
Completed	`NCT03722212` - Early Diagnosis of the GLUT1 Deficiency Syndrome With a Blood Based Test	N/A
Recruiting	`NCT05973929` - Movement Disorders in Multiple Sclerosis Patients
Terminated	`NCT02823158` - Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIM	N/A
Enrolling by invitation	`NCT01210781` - Target Planning for Placement of DBS-electrodes and Follow-up of the Clinical Efficacy of Stimulation
Enrolling by invitation	`NCT00355927` - Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.	N/A
Completed	`NCT00037167` - Effects of Exercise Poles on Older Adults During Exercise Walking	Phase 1/Phase 2
Recruiting	`NCT04784494` - MST for Parkinson's Disease	N/A
Terminated	`NCT03270189` - Effect of the Visual Information Change in Functional Dystonia	N/A
Recruiting	`NCT04176692` - The Effects of Muscle Characteristics on the Control of Shoulder Complex During Functional Movements
Recruiting	`NCT04061135` - Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders	N/A
Suspended	`NCT04912115` - Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia	Phase 2
Completed	`NCT00500994` - Neurobiology of Functional Movement Disorder and Non-Epileptic Seizures	Early Phase 1
Completed	`NCT04536987` - Robot Therapy for Rehabilitation of Hand Movement After Stroke	Phase 2
Recruiting	`NCT00001208` - Botulinum Toxin for the Treatment of Involuntary Movement Disorders
Completed	`NCT02392078` - Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System
Completed	`NCT00552474` - Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease	N/A
Not yet recruiting	`NCT05032911` - Sensorimotor Control in People With and Without Neck Pain

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Electroacupuncture of Scalp Motor Area to Improve Post-Stroke Wrist Dyskinesia

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms